Skip to main content

Table 1 Characteristics of the patients with chronic obstructive pulmonary disease

From: Nitroglycerin can facilitate weaning of difficult-to-wean chronic obstructive pulmonary disease patients: a prospective interventional non-randomized study

Patient

Days of MV

ET ID, mm

MIP, cm H2O

Cause of acute respiratory failure/Prior cardiovascular disease

Failed trial duration on Control day, minutes

Weaning trial outcome on Study day

Extubation outcome

ICU outcome

1

15

9

-20

GI hemorrhage/

Hypertension

10

S

S

A

2

11

8

-40

AAA repair/

Hypertension, CAD

30

S

S

A

3

9

8.5

-25

Acute exacerbation/

None

15

S

S

A

4

5

8.5

-30

Acute exacerbation/

CP

30

S

S

A

5

28

8a

-25

Acute exacerbation/

Hypertension, CP

110

S

NA

D

6

8

8.5a

-30

Acute exacerbation/

None

60

S

NA

A

7

9

8.5a

-28

Acute exacerbation/

CAD

45

S

NA

A

8

6

8

-30

Acute exacerbation/

CAD

110

S

S

A

9

10

8

-40

Acute exacerbation/

Hypertension, CP

60

S

S

A

10

9

8

-50

Acute exacerbation/

Hypertension

30

S

S

A

11

12

7.5

-22

Gastrectomy/

None

30

F

NA

A

12

10

8.5

-30

Acute exacerbation/

CAD

55

S

F

D

  1. a, tracheostomy tube; A, alive; AAA, abdominal aortic aneurysm; CAD, coronary artery disease; CP, cor pulmonale; D, died; ET, endotracheal tube; F, failure; GI, gastrointestinal; ICU, intensive care unit; ID, internal diameter of tracheostomy tube; MIP, maximum inspiratory pressure; MV, mechanical ventilation; NA, not applicable; S, success.